Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$13 |
Replacement Appendix 3Y - Mark Edwards
|
22 Jul 2025 1:24PM |
$0.002 |
$0.002 |
fallen by
0%
|
|
Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Ceasing to be a substantial holder
|
22 Jul 2025 1:19PM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
Move Logistics Group Limited (MOV) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$25 |
MOVE Continues Positive Progress - Achieves FY25 Targets
|
22 Jul 2025 1:08PM |
$0.215 |
$0.195 |
fallen by
9.30%
|
|
MOV - Price-sensitive ASX Announcement
Full Release
Key Points
- MOV has achieved or is on track to meet FY25 targets.
- Operational improvements have led to increased profitability.
- Efficiency programs have driven down costs.
- Customer service and safety remain top priorities.
- Recent acquisitions have been successfully integrated.
- Service offerings have been optimized for market needs.
- Digital transformation and strategic partnerships are supporting growth.
- The company is maintaining a focus on sustainability.
- MOV continues to deliver value for shareholders with a strong financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$9 |
Production Target Retraction
|
22 Jul 2025 12:57PM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd (KNG) has retracted its previously released production target for the Leliyn Graphite Project.
- The production target and related economic information were released before the completion of a compliant scoping study.
- Such disclosure was not in accordance with ASX Listing Rules and JORC Code requirements.
- Any references to production targets, project economics, or scoping study outcomes should be disregarded until further notice.
- Kingsland Minerals is taking steps to ensure full compliance with regulatory requirements in future announcements.
- The company remains committed to transparency and accurate communication with shareholders and investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$574 |
Daily Net Tangible Asset Statement
|
22 Jul 2025 12:51PM |
$1.175 |
$1.180 |
risen by
0.43%
|
|
Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$41 |
Notification regarding unquoted securities - EYE
|
22 Jul 2025 12:47PM |
$0.150 |
$0.145 |
fallen by
3.33%
|
|
Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$41 |
Application for quotation of securities - EYE
|
22 Jul 2025 12:41PM |
$0.150 |
$0.145 |
fallen by
3.33%
|
|
Metalstech Limited (MTC) ORDINARY FULLY PAID |
Materials |
$30 |
Application for quotation of securities - MTC
|
22 Jul 2025 12:29PM |
$0.130 |
$0.135 |
risen by
3.85%
|
|
Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,774 |
Notification regarding unquoted securities - OCL
|
22 Jul 2025 12:25PM |
$18.590 |
$18.560 |
fallen by
0.16%
|
|
Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$1,085 |
Net Tangible Asset Backing
|
22 Jul 2025 12:24PM |
$2.080 |
$2.070 |
fallen by
0.48%
|
|
Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$39 |
Application for quotation of securities - LMG
|
22 Jul 2025 12:16PM |
$0.013 |
$0.015 |
risen by
20%
|
|
Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
22 Jul 2025 12:15PM |
$0.015 |
$0.014 |
fallen by
6.67%
|
|
NWM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities and cash flow for the period ending 31 March 2024.
- Significant exploration activities occurred at the Bali Copper Project and Arunta West Project.
- A heritage survey was completed at the Bali Copper Project to facilitate further drilling.
- Norwest received a government co-funding grant for drilling at Arunta West.
- The company advanced its Rare Earth Element (REE) exploration programs.
- Cash flow report outlines expenditure primarily on exploration, evaluation, and administration.
- Share issuance activities were conducted under the Option Exercise Program.
- The report provides a summary of available cash and financial position at the end of the quarter.
- Upcoming priorities include further drilling, exploration, and project development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$163 |
Investor Presentation
|
22 Jul 2025 12:07PM |
$0.405 |
$0.320 |
fallen by
20.99%
|
|
NRW Holdings Limited (NWH) ORDINARY FULLY PAID |
Industrials |
$1,482 |
Becoming a substantial holder from MUFG
|
22 Jul 2025 11:58AM |
$3.170 |
$3.240 |
risen by
2.21%
|
|
King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
22 Jul 2025 11:49AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
KRR - Price-sensitive ASX Announcement
Full Release
Key Points
- KRR released its Quarterly Activities Report and Appendix 5B for the quarter ending 30 September 2023.
- Primary focus was on the Speewah High Purity Alumina (HPA) project in Western Australia.
- A Pre-Feasibility Study (PFS) was completed, showing positive project economics and viability.
- Next steps for the project include pilot plant test work and progressing permitting and approvals.
- Environmental and heritage surveys were conducted to facilitate project development.
- Engagement with government agencies and continued local community consultation occurred.
- Cash expenditures were detailed, with a focus on project and corporate costs.
- KRR maintained a strong cash position at the end of the quarter.
- There was no mining production or sales during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$27,698 |
Advance Notice - 2025 Full Year Results
|
22 Jul 2025 11:43AM |
$20.440 |
$20.650 |
risen by
1.03%
|
|
Eildon Capital Group (EDC) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$36 |
Application for quotation of securities - EDC
|
22 Jul 2025 11:38AM |
$0.850 |
$0.750 |
fallen by
11.76%
|
|
I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$15 |
Trading Halt
|
22 Jul 2025 11:38AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- IS3 (I Synergy Group Limited) requested a trading halt on 11 June 2024.
- The trading halt is pending an announcement regarding a material transaction.
- The halt will remain until either 13 June 2024 or the material transaction announcement is released.
- IS3 assured its commitment to market transparency.
- The company is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$9 |
Jun25 Appendix 4C Cash Flow Report
|
22 Jul 2025 11:37AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report for InhaleRx Limited for the quarter ending 30 June 2024
- Net cash used in operating activities with breakdowns for research and development, staff, and administrative costs
- Minor receipt of government grants during the quarter
- Investment expenditure primarily related to property, plant, and equipment
- Financing activities impacted by share issue proceeds and borrowing repayments
- Closing cash and cash equivalents reported for the quarter
- Anticipated cash outflows for the next quarter detailed
- Director's statements on compliance and accuracy of financial reporting included
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$9 |
Jun25 Quarterly Activities Report
|
22 Jul 2025 11:36AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced clinical trials for inhaled cannabinoid therapeutics.
- Progress made on regulatory submissions for IRX products.
- Continued focus on intellectual property protection.
- Engagement in partnership and collaboration activities.
- Financial updates and cash position commentary provided.
- Positive outlook for future quarters with projected milestones.
- Corporate governance and risk disclosures included.
- Strategic steps taken to secure and commercialize product pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$147 |
Ceasing to be a substantial holder
|
22 Jul 2025 11:32AM |
$0.265 |
$0.240 |
fallen by
9.43%
|
|
Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$147 |
s708A Notice
|
22 Jul 2025 11:29AM |
$0.265 |
$0.240 |
fallen by
9.43%
|
|
Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$147 |
Application for quotation of securities - MM8
|
22 Jul 2025 11:27AM |
$0.265 |
$0.240 |
fallen by
9.43%
|
|
Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$147 |
Application for quotation of securities - MM8
|
22 Jul 2025 11:25AM |
$0.265 |
$0.240 |
fallen by
9.43%
|
|
The Reject Shop Limited (TRS) ORDINARY FULLY PAID |
Consumer Discretionary |
$259 |
Final Director's Interest Notices
|
22 Jul 2025 11:24AM |
$6.680 |
$6.680 |
fallen by
0%
|
|